Journal profile · Ophthalmology
Ocular Immunology and Inflammation
ISSN 0927-3948 · eISSN 1744-5078 · Taylor and Francis Ltd. · NETHERLANDS · Quarterly · Founded 1993
Ocular Immunology and Inflammation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.72; hybrid open access; APC charged, amount not published; median 95 days to acceptance (139 articles, last 24 months); community-reported acceptance: easy; 300 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Ocular Immunology and Inflammation is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions and Retinal Diseases and Treatments, together about 47.9% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Ocular Immunology and Inflammation is a subscription-based, peer-reviewed journal that focuses on publishing high-quality research and clinical studies related to the ocular inflammatory response and its regulation by the immune system. The journal’s audience includes ophthalmologists, vision scientists, and researchers interested in the mechanisms, diagnosis, and treatment of ocular inflammation and Immune-related ocular conditions. The journal has a special interest in advancing knowledge on the basic mechanisms of ocular inflammation, as well as providing new insights into the diagnosis and treatment of uveitis, and inflammation affecting the cornea, retina, and optic nerve. The journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articles, and all articles received by the Journal will be subject to Single Anonymous peer review. Authors can choose to publish gold open access in this journal. Read the Instructions for Authors for information on how to submit your article.
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Editor-in-chief Jennifer E. ThornePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ocular Diseases and Behçet’s SyndromeMedicine30.8%
- Retinal and Optic ConditionsMedicine9.5%
- Retinal Diseases and TreatmentsMedicine7.6%
- Ocular Infections and TreatmentsMedicine6.7%
- Sarcoidosis and Beryllium Toxicity ResearchMedicine4.6%
- Ocular Surface and Contact LensMedicine4.5%
- Cytomegalovirus and herpesvirus researchMedicine3.6%
- CNS Lymphoma Diagnosis and TreatmentMedicine2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest, OCLC, Adis International Ltd., CABI, EBSCOhost, MetaPress
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.72LetPub ·
- Impact factor (publisher) 2025
- 1.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- CiteScore (publisher) 2025
- 3.5Publisher website ·
- SJR 2026-06
- 0.72LetPub ·
- SJR (publisher) 2025
- 0.72Publisher website ·
- SNIP 2026-06
- 0.96LetPub ·
- SNIP (publisher) 2025
- 0.96Publisher website ·
- h-index
- 48LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 1,895OpenAlex ·
- 2-year mean citedness
- 1.66OpenAlex ·
- Self-citation rate
- 17.6%LetPub ·
- Share of gold OA articles
- 5.06%LetPub ·
Volume
- Articles per year
- 281LetPub ·
- Downloads per year (publisher)
- 305,000Publisher website ·
Articles by year OpenAlex count · 4,366 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 213 | 31 | 45 |
| 2025 | 300 | 37 | 403 |
| 2024 | 264 | 57 | 842 |
| 2023 | 299 | 57 | 1,582 |
| 2022 | 309 | 48 | 2,261 |
| 2021 | 309 | 56 | 3,757 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
95 daysMedian, submission to acceptance · P25–P75 64 days – 134 days
- Acceptance to online
- median 17 days (139 articles)
- Submission to online
- median 124 days
- Sample
- 139 articles with submission and acceptance dates (549 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 28%Publisher website ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 38 daysPublisher website ·
- Acceptance to publication
- 19 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- brief reportsThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
- editorialsThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
- letter to the editorThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
- method articlesThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
- research articlesThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
- review articleThe journal welcomes for consideration the following Research Articles, Brief Reports, Letter to the Editor, Review Article, Editorials, and Method articlesLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Gold open access option Model summary
Ocular Immunology and Inflammation is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discover…
Source ↗Publisher website ·- Peer review
Single Anonymous peer review Model summary
all articles received by the Journal will be subject to Single Anonymous peer review
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 1993
- ISSN
- 0927-3948
- Electronic ISSN
- 1744-5078
- Society / sponsor
- International Uveitis Study Group
- Latest issue on the website
- Volume 34, Issue 6 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Ocular Immunology and Inflammation
What CAS zone is Ocular Immunology and Inflammation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Ocular Immunology and Inflammation is in Zone 4 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Ocular Immunology and Inflammation?
The latest impact factor listed by LetPub is 1.72; CiteScore 3.5, h-index 86.
How long does peer review take at Ocular Immunology and Inflammation?
Based on the dates recorded on 139 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 64–134 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 28%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Ocular Immunology and Inflammation?
According to LetPub and DOAJ records, Ocular Immunology and Inflammation is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Ocular Immunology and Inflammation open access, and what is the APC?
Ocular Immunology and Inflammation is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .